APO RESEARCH · REPORT
Life Cycle Assessment Services for Pharmaceutical Packaging
Selected research
Market Outlook & Growth Opportunities
Global Life Cycle Assessment Services for Pharmaceutical Packaging Market Outlook and Growth Opportunities 2026
Market perspective
The global Life Cycle Assessment Services for Pharmaceutical Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Life Cycle Assessment Services for Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Life Cycle Assessment Services for Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Life Cycle Assessment Services for Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Life Cycle Assessment Services for Pharmaceutical Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Life Cycle Assessment Services for Pharmaceutical Packaging market include Bureau Veritas SA, TÜV SÜD AG, TÜV Rheinland AG, DNV AS, UL Solutions Inc., SCS Global Services, DEKRA SE, RINA S.p.A. and Sphera Solutions, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Life Cycle Assessment Services for Pharmaceutical Packaging market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Life Cycle Assessment Services for Pharmaceutical Packaging and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Life Cycle Assessment Services for Pharmaceutical Packaging revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Life Cycle Assessment Services for Pharmaceutical Packaging market.
Life Cycle Assessment Services for Pharmaceutical Packaging Segment by Company
Bureau Veritas SA
TÜV SÜD AG
TÜV Rheinland AG
DNV AS
UL Solutions Inc.
SCS Global Services
DEKRA SE
RINA S.p.A.
Sphera Solutions, Inc.
One Click LCA Oy
Ecochain Technologies B.V.
Trayak LLC
EarthShift Global, LLC
Quantis
Anthesis Group
Ramboll Group A/S
ERM CVS
SLR Consulting Limited
EPD International AB
Sustainable Management Promotion Organization
CTI Certification Co., Ltd.
CIRS Group
SGS S.A.
Eurofins Scientific SE
Intertek Group plc
Life Cycle Assessment Services for Pharmaceutical Packaging Segment by Type
Life Cycle Assessment Study Services
Life Cycle Assessment Critical Review Services
Environmental Product Declaration Support Services
Packaging Environmental Impact Modeling Support Services
Life Cycle Assessment Services for Pharmaceutical Packaging Segment by Application
Primary Pharmaceutical Packaging Applications
Secondary Pharmaceutical Packaging Applications
Transport Pharmaceutical Packaging Applications
All Pharmaceutical Packaging Levels
Life Cycle Assessment Services for Pharmaceutical Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Life Cycle Assessment Services for Pharmaceutical Packaging status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Life Cycle Assessment Services for Pharmaceutical Packaging key companies, revenue, market share, and recent developments.
3. To split the Life Cycle Assessment Services for Pharmaceutical Packaging breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Life Cycle Assessment Services for Pharmaceutical Packaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Life Cycle Assessment Services for Pharmaceutical Packaging significant trends, drivers, influence factors in global and regions.
6. To analyze Life Cycle Assessment Services for Pharmaceutical Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Cycle Assessment Services for Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life Cycle Assessment Services for Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Cycle Assessment Services for Pharmaceutical Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life Cycle Assessment Services for Pharmaceutical Packaging industry.
Chapter 3: Detailed analysis of Life Cycle Assessment Services for Pharmaceutical Packaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Life Cycle Assessment Services for Pharmaceutical Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Life Cycle Assessment Services for Pharmaceutical Packaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Life Cycle Assessment Study Services
- Life Cycle Assessment Critical Review Services
- Environmental Product Declaration Support Services
- Packaging Environmental Impact Modeling Support Services
Applications
- Primary Pharmaceutical Packaging Applications
- Secondary Pharmaceutical Packaging Applications
- Transport Pharmaceutical Packaging Applications
- All Pharmaceutical Packaging Levels
Companies covered
- Bureau Veritas SA
- TÜV SÜD AG
- TÜV Rheinland AG
- DNV AS
- UL Solutions Inc.
- SCS Global Services
- DEKRA SE
- RINA S.p.A.
- Sphera Solutions, Inc.
- One Click LCA Oy
- Ecochain Technologies B.V.
- Trayak LLC
- EarthShift Global, LLC
- Quantis
- Anthesis Group
- Ramboll Group A/S
- ERM CVS
- SLR Consulting Limited
- EPD International AB
- Sustainable Management Promotion Organization
- CTI Certification Co., Ltd.
- CIRS Group
- SGS S.A.
- Eurofins Scientific SE
- Intertek Group plc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Life Cycle Assessment Services for Pharmaceutical Packaging Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Life Cycle Assessment Services for Pharmaceutical Packaging Market Dynamics
- 2.1 Life Cycle Assessment Services for Pharmaceutical Packaging Industry Trends
- 2.2 Life Cycle Assessment Services for Pharmaceutical Packaging Industry Drivers
- 2.3 Life Cycle Assessment Services for Pharmaceutical Packaging Industry Opportunities and Challenges
- 2.4 Life Cycle Assessment Services for Pharmaceutical Packaging Industry Restraints
3 Life Cycle Assessment Services for Pharmaceutical Packaging Market by Company
- 3.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Company Revenue Ranking in 2025
- 3.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Revenue by Company (2021-2026)
- 3.3 Global Life Cycle Assessment Services for Pharmaceutical Packaging Company Ranking (2024-2026)
- 3.4 Global Life Cycle Assessment Services for Pharmaceutical Packaging Company Manufacturing Base and Headquarters
- 3.5 Global Life Cycle Assessment Services for Pharmaceutical Packaging Company Product Type and Application
- 3.6 Global Life Cycle Assessment Services for Pharmaceutical Packaging Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Life Cycle Assessment Services for Pharmaceutical Packaging Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Life Cycle Assessment Services for Pharmaceutical Packaging Market by Type
- 4.1 Life Cycle Assessment Services for Pharmaceutical Packaging Type Introduction
- 4.1.1 Life Cycle Assessment Study Services
- 4.1.2 Life Cycle Assessment Critical Review Services
- 4.1.3 Environmental Product Declaration Support Services
- 4.1.4 Packaging Environmental Impact Modeling Support Services
- 4.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Type
- 4.2.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Type (2021-2032)
- 4.2.3 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type (2021-2032)
5 Life Cycle Assessment Services for Pharmaceutical Packaging Market by Application
- 5.1 Life Cycle Assessment Services for Pharmaceutical Packaging Application Introduction
- 5.1.1 Primary Pharmaceutical Packaging Applications
- 5.1.2 Secondary Pharmaceutical Packaging Applications
- 5.1.3 Transport Pharmaceutical Packaging Applications
- 5.1.4 All Pharmaceutical Packaging Levels
- 5.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Application
- 5.2.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Application (2021-2032)
- 5.2.3 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application (2021-2032)
6 Life Cycle Assessment Services for Pharmaceutical Packaging Regional Value Analysis
- 6.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Region (2021-2032)
- 6.2.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Region: 2021-2026
- 6.2.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.3.2 North America Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.4.2 Europe Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.6.2 South America Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
7 Life Cycle Assessment Services for Pharmaceutical Packaging Country-level Value Analysis
- 7.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Country (2021-2032)
- 7.2.1 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Country (2021-2026)
- 7.2.2 Global Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.7.2 France Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.14.2 China Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.17.2 India Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Life Cycle Assessment Services for Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bureau Veritas SA
- 8.1.1 Bureau Veritas SA Company Information
- 8.1.2 Bureau Veritas SA Business Overview
- 8.1.3 Bureau Veritas SA Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.1.4 Bureau Veritas SA Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.1.5 Bureau Veritas SA Recent Developments
- 8.2 TÜV SÜD AG
- 8.2.1 TÜV SÜD AG Company Information
- 8.2.2 TÜV SÜD AG Business Overview
- 8.2.3 TÜV SÜD AG Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.2.4 TÜV SÜD AG Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.2.5 TÜV SÜD AG Recent Developments
- 8.3 TÜV Rheinland AG
- 8.3.1 TÜV Rheinland AG Company Information
- 8.3.2 TÜV Rheinland AG Business Overview
- 8.3.3 TÜV Rheinland AG Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.3.4 TÜV Rheinland AG Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.3.5 TÜV Rheinland AG Recent Developments
- 8.4 DNV AS
- 8.4.1 DNV AS Company Information
- 8.4.2 DNV AS Business Overview
- 8.4.3 DNV AS Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.4.4 DNV AS Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.4.5 DNV AS Recent Developments
- 8.5 UL Solutions Inc.
- 8.5.1 UL Solutions Inc. Company Information
- 8.5.2 UL Solutions Inc. Business Overview
- 8.5.3 UL Solutions Inc. Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.5.4 UL Solutions Inc. Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.5.5 UL Solutions Inc. Recent Developments
- 8.6 SCS Global Services
- 8.6.1 SCS Global Services Company Information
- 8.6.2 SCS Global Services Business Overview
- 8.6.3 SCS Global Services Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.6.4 SCS Global Services Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.6.5 SCS Global Services Recent Developments
- 8.7 DEKRA SE
- 8.7.1 DEKRA SE Company Information
- 8.7.2 DEKRA SE Business Overview
- 8.7.3 DEKRA SE Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.7.4 DEKRA SE Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.7.5 DEKRA SE Recent Developments
- 8.8 RINA S.p.A.
- 8.8.1 RINA S.p.A. Company Information
- 8.8.2 RINA S.p.A. Business Overview
- 8.8.3 RINA S.p.A. Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.8.4 RINA S.p.A. Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.8.5 RINA S.p.A. Recent Developments
- 8.9 Sphera Solutions, Inc.
- 8.9.1 Sphera Solutions, Inc. Company Information
- 8.9.2 Sphera Solutions, Inc. Business Overview
- 8.9.3 Sphera Solutions, Inc. Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.9.4 Sphera Solutions, Inc. Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.9.5 Sphera Solutions, Inc. Recent Developments
- 8.10 One Click LCA Oy
- 8.10.1 One Click LCA Oy Company Information
- 8.10.2 One Click LCA Oy Business Overview
- 8.10.3 One Click LCA Oy Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.10.4 One Click LCA Oy Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.10.5 One Click LCA Oy Recent Developments
- 8.11 Ecochain Technologies B.V.
- 8.11.1 Ecochain Technologies B.V. Company Information
- 8.11.2 Ecochain Technologies B.V. Business Overview
- 8.11.3 Ecochain Technologies B.V. Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.11.4 Ecochain Technologies B.V. Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.11.5 Ecochain Technologies B.V. Recent Developments
- 8.12 Trayak LLC
- 8.12.1 Trayak LLC Company Information
- 8.12.2 Trayak LLC Business Overview
- 8.12.3 Trayak LLC Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.12.4 Trayak LLC Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.12.5 Trayak LLC Recent Developments
- 8.13 EarthShift Global, LLC
- 8.13.1 EarthShift Global, LLC Company Information
- 8.13.2 EarthShift Global, LLC Business Overview
- 8.13.3 EarthShift Global, LLC Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.13.4 EarthShift Global, LLC Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.13.5 EarthShift Global, LLC Recent Developments
- 8.14 Quantis
- 8.14.1 Quantis Company Information
- 8.14.2 Quantis Business Overview
- 8.14.3 Quantis Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.14.4 Quantis Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.14.5 Quantis Recent Developments
- 8.15 Anthesis Group
- 8.15.1 Anthesis Group Company Information
- 8.15.2 Anthesis Group Business Overview
- 8.15.3 Anthesis Group Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.15.4 Anthesis Group Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.15.5 Anthesis Group Recent Developments
- 8.16 Ramboll Group A/S
- 8.16.1 Ramboll Group A/S Company Information
- 8.16.2 Ramboll Group A/S Business Overview
- 8.16.3 Ramboll Group A/S Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.16.4 Ramboll Group A/S Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.16.5 Ramboll Group A/S Recent Developments
- 8.17 ERM CVS
- 8.17.1 ERM CVS Company Information
- 8.17.2 ERM CVS Business Overview
- 8.17.3 ERM CVS Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.17.4 ERM CVS Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.17.5 ERM CVS Recent Developments
- 8.18 SLR Consulting Limited
- 8.18.1 SLR Consulting Limited Company Information
- 8.18.2 SLR Consulting Limited Business Overview
- 8.18.3 SLR Consulting Limited Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.18.4 SLR Consulting Limited Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.18.5 SLR Consulting Limited Recent Developments
- 8.19 EPD International AB
- 8.19.1 EPD International AB Company Information
- 8.19.2 EPD International AB Business Overview
- 8.19.3 EPD International AB Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.19.4 EPD International AB Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.19.5 EPD International AB Recent Developments
- 8.20 Sustainable Management Promotion Organization
- 8.20.1 Sustainable Management Promotion Organization Company Information
- 8.20.2 Sustainable Management Promotion Organization Business Overview
- 8.20.3 Sustainable Management Promotion Organization Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.20.4 Sustainable Management Promotion Organization Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.20.5 Sustainable Management Promotion Organization Recent Developments
- 8.21 CTI Certification Co., Ltd.
- 8.21.1 CTI Certification Co., Ltd. Company Information
- 8.21.2 CTI Certification Co., Ltd. Business Overview
- 8.21.3 CTI Certification Co., Ltd. Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.21.4 CTI Certification Co., Ltd. Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.21.5 CTI Certification Co., Ltd. Recent Developments
- 8.22 CIRS Group
- 8.22.1 CIRS Group Company Information
- 8.22.2 CIRS Group Business Overview
- 8.22.3 CIRS Group Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.22.4 CIRS Group Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.22.5 CIRS Group Recent Developments
- 8.23 SGS S.A.
- 8.23.1 SGS S.A. Company Information
- 8.23.2 SGS S.A. Business Overview
- 8.23.3 SGS S.A. Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.23.4 SGS S.A. Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.23.5 SGS S.A. Recent Developments
- 8.24 Eurofins Scientific SE
- 8.24.1 Eurofins Scientific SE Company Information
- 8.24.2 Eurofins Scientific SE Business Overview
- 8.24.3 Eurofins Scientific SE Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.24.4 Eurofins Scientific SE Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.24.5 Eurofins Scientific SE Recent Developments
- 8.25 Intertek Group plc
- 8.25.1 Intertek Group plc Company Information
- 8.25.2 Intertek Group plc Business Overview
- 8.25.3 Intertek Group plc Life Cycle Assessment Services for Pharmaceutical Packaging Revenue and Gross Margin (2021-2026)
- 8.25.4 Intertek Group plc Life Cycle Assessment Services for Pharmaceutical Packaging Product Portfolio
- 8.25.5 Intertek Group plc Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst